Pliant Therapeutics Inc. (PLRX): Price and Financial Metrics

Pliant Therapeutics Inc. (PLRX): $14.52

0.45 (+3.20%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add PLRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#248 of 328

in industry

PLRX Price/Volume Stats

Current price $14.52 52-week high $19.62
Prev. close $14.07 52-week low $10.22
Day low $14.10 Volume 333,000
Day high $14.81 Avg. volume 451,924
50-day MA $12.85 Dividend yield N/A
200-day MA $13.62 Market Cap 882.83M

PLRX Stock Price Chart Interactive Chart >


Pliant Therapeutics Inc. (PLRX) Company Bio


Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.


PLRX Latest News Stream


Event/Time News Detail
Loading, please wait...

PLRX Latest Social Stream


Loading social stream, please wait...

View Full PLRX Social Stream

PLRX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!